IntoCell, Inc. (KOSDAQ:287840)
39,500
-3,400 (-7.93%)
At close: Mar 9, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 592.97 billion as of March 9, 2026.
Market Cap
592.97B
Enterprise Value
572.75B
Revenue
1.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
39,500.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 592.97B, an increase of 20.44%. That is a compound annual growth rate of 26.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 644.01B | -25.21% |
| Dec 30, 2025 | 861.05B | 74.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 695.70B |
| Curocell | 763.43B |
| S.Biomedics | 448.34B |
| Y-Biologics | 363.52B |
| curacle co.,ltd. | 354.71B |
| ROKIT Healthcare | 1,210.28B |
| NIBEC | 338.70B |
| Inventage Lab | 1,267.98B |